Gerald D. Cagle - Net Worth and Insider Trading

Gerald D. Cagle Net Worth

The estimated net worth of Gerald D. Cagle is at least $302,644 dollars as of 2024-04-25. Gerald D. Cagle is the Director of Aerie Pharmaceuticals Inc and owns about 16,550 shares of Aerie Pharmaceuticals Inc (AERI) stock worth over $252,388. Gerald D. Cagle is also the Director of Clearside Biomedical Inc and owns about 37,505 shares of Clearside Biomedical Inc (CLSD) stock worth over $50,257. Details can be seen in Gerald D. Cagle's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gerald D. Cagle has not made any transactions after 2020-05-08 and currently still holds the listed stock(s).

Transaction Summary of Gerald D. Cagle

To

Gerald D. Cagle Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gerald D. Cagle owns 3 companies in total, including CalciMedica Inc (CALC) , Aerie Pharmaceuticals Inc (AERI) , and Clearside Biomedical Inc (CLSD) .

Click here to see the complete history of Gerald D. Cagle’s form 4 insider trades.

Insider Ownership Summary of Gerald D. Cagle

Ticker Comapny Transaction Date Type of Owner
CALC CalciMedica Inc 2020-09-24 director
AERI Aerie Pharmaceuticals Inc 2020-05-08 director
CLSD Clearside Biomedical Inc 2018-03-22 director

Gerald D. Cagle Latest Holdings Summary

Gerald D. Cagle currently owns a total of 2 stocks. Among these stocks, Gerald D. Cagle owns 16,550 shares of Aerie Pharmaceuticals Inc (AERI) as of May 8, 2020, with a value of $252,388 and a weighting of 83.39%. Gerald D. Cagle also owns 37,505 shares of Clearside Biomedical Inc (CLSD) as of March 22, 2018, with a value of $50,257 and a weighting of 16.61%.

Latest Holdings of Gerald D. Cagle

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AERI Aerie Pharmaceuticals Inc 2020-05-08 16,550 15.25 252,388
CLSD Clearside Biomedical Inc 2018-03-22 37,505 1.34 50,257

Holding Weightings of Gerald D. Cagle


Gerald D. Cagle Form 4 Trading Tracker

According to the SEC Form 4 filings, Gerald D. Cagle has made a total of 1 transactions in Aerie Pharmaceuticals Inc (AERI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aerie Pharmaceuticals Inc is the sale of 5,000 shares on May 8, 2020, which brought Gerald D. Cagle around $76,350.

According to the SEC Form 4 filings, Gerald D. Cagle has made a total of 0 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years. The most-recent trade in Clearside Biomedical Inc is the acquisition of 7,500 shares on March 22, 2018, which cost Gerald D. Cagle around $89,175.

Insider Trading History of Gerald D. Cagle

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gerald D. Cagle Trading Performance

GuruFocus tracks the stock performance after each of Gerald D. Cagle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerald D. Cagle is 19.56%. GuruFocus also compares Gerald D. Cagle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerald D. Cagle within 3 months outperforms 7 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gerald D. Cagle's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gerald D. Cagle

Average Return

-0.56%

Average return per transaction

Outperforming Transactions

60%

6 out of 10 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.23 19.56 3.6 -0.56 -28.47 -25.03
Relative Return to S&P 500(%) 12.61 15.42 -0.83 -11.43 -36.07 -35.59

Gerald D. Cagle Ownership Network

Ownership Network List of Gerald D. Cagle

No Data

Ownership Network Relation of Gerald D. Cagle


Gerald D. Cagle Owned Company Details

What does CalciMedica Inc do?

Who are the key executives at CalciMedica Inc?

Gerald D. Cagle is the director of CalciMedica Inc. Other key executives at CalciMedica Inc include director & 10 percent owner & Chief Business Officer Eric W Roberts , 10 percent owner Sanderling Venture Partners Vi Co Investment Fund Lp , and director & 10 percent owner Fred A Middleton .

CalciMedica Inc (CALC) Insider Trades Summary

Over the past 18 months, Gerald D. Cagle made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 65,404 shares made by Eric W Roberts , a net purchase of 20,768 shares made by A. Rachel Leheny , and a net purchase of 691,098 shares made by Fred A Middleton .

In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,505,415 shares were bought by its insiders, resulting in a net purchase of 1,505,415 shares.

CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CalciMedica Inc Insider Transactions

No Available Data

Gerald D. Cagle Mailing Address

Above is the net worth, insider trading, and ownership report for Gerald D. Cagle. You might contact Gerald D. Cagle via mailing address: 135 U.s. Highway 206, Suite 15, Bedminster Nj 07921.

Discussions on Gerald D. Cagle

No discussions yet.